M&A Deal Summary

Thompson Street Capital Partners Acquires Vector Laboratories

On September 7, 2021, private equity firm Thompson Street Capital Partners acquired medical products company Vector Laboratories from Maravai

Acquisition Highlights
  • This is Thompson Street Capital Partners’ 4th transaction in the Medical Products sector.
  • This is Thompson Street Capital Partners’ 64th transaction in the United States.
  • This is Thompson Street Capital Partners’ 3rd transaction in California.

M&A Deal Summary

Date 2021-09-07
Target Vector Laboratories
Sector Medical Products
Buyer(s) Thompson Street Capital Partners
Sellers(s) Maravai
Deal Type Divestiture

Target

Vector Laboratories

Newark, California, United States
Vector Laboratories is a provider of life science products, including labeling and detection reagents, that help medical and scientific researchers visualize cells in experiments that are central to the understanding of cancer and other diseases. Vector Laboratories was founded in 1976 and is based in Newark, California.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Thompson Street Capital Partners

St. Louis, Missouri, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 2001
PE ASSETS 2.6B USD
Size Large
Type Sector Agnostic
DESCRIPTION

Thompson Street Capital Partners is a private equity firm that targets control stakes in profitable, mid-sized North American companies with $5 to $20 million of EBITDA. Thompson Street looks for family businesses, private companies seeking liquidity, corporate divestitures, and public companies going private. Areas of interest include healthcare services, business services, electronics, information technology, and engineered products companies. Thompson Street will not consider investments in start-ups, early stage companies, or real estate. Thompson Street Capital was founded in 2000 and is based in St. Louis, Missouri.


DEAL STATS #
Overall 64 of 73
Sector (Medical Products) 4 of 4
Type (Divestiture) 3 of 3
State (California) 3 of 4
Country (United States) 64 of 72
Year (2021) 4 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-08-05 StayLock Storage

St. Louis, Missouri, United States

StayLock Storage is a provider of self-storage, under the StayLock banner. The facilities feature 916 non-climate controlled storage units and 37 spaces for boat and vehicle parking with five locations in Northwest Indiana. Locations include Demotte, Hebron, Kouts, Wheatfield, and Winfield (Lake of the Four Seasons), Indiana. StayLock Storage was founded in 2016 and is based in St. Louis, Missouri.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-01 PestCo

Clayton, Missouri, United States

PestCo is a holding company of residential and commercial pest prevention and control services. PestCo is based in Clayton, Missouri.

Buy -

Seller(S) 1

SELLER

Maravai

San Diego, California, United States

Category Company
Founded 2020
Sector Life Science
Employees570
Revenue 289M USD (2023)
DESCRIPTION

Maravai’s mission is to build a transformative company in the in vitro diagnostics and life sciences tools markets by acquiring outstanding businesses in these spaces and accelerating their growth. Maravai was founded in 2020 and is based in San Diego, California.


DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Divestiture) 1 of 1
State (California) 1 of 1
Country (United States) 1 of 1
Year (2021) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-03-17 MockV Solutions

Rockville, Maryland, United States

MockV Solutions is a biotechnology company developing a series of analytical kits that will enable benchtop scientists to easily and economically quantify viral clearance in industrial processes. MockV Solutions is based in Rockville, Maryland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-28 MyChem

San Diego, California, United States

MyChem is a privately held provider of proprietary, ultra-pure nucleotides to customers in the diagnostics, pharma, genomics, and research markets. MyChem products include modified nucleotides and other inputs used for mRNA synthesis. MyChem is based in San Diego, California.

Buy $240M